Home › Drugs › Triethanolamine Salicylate

Triethanolamine Salicylate

FDA Drug Information • Also known as: Salicor

Brand Names
Salicor
Route
TRANSDERMAL
Dosage Form
PATCH
Product Type
HUMAN PRESCRIPTION DRUG

Description

DESCRIPTION Salicor™ is an external analgesic product containing 10% triethanolamine salicylate as the active ingredient. Triethanolamine salicylate is an organic compound formed between triethanolamine and salicylic acid, where triethanolamine neutralizes the acidity of salicylic acid. This external analgesic is designed for temporary relief of minor pain associated with arthritis, simple backache, muscle strains, sprains, and bruises. Unlike other external analgesics, triethanolamine salicylate has no distinct odor, which improves patient acceptability.

What Is Triethanolamine Salicylate Used For?

INDICATION AND USAGE Salicor™ is indicated for the temporary relief of minor aches and pains of muscles and joints associated with: arthritis, simple backache, muscle strains and sprains, bruises, bursitis, and dysmenorrhea. Salicor™ provides a localized analgesic effect directly at the site of pain, offering convenience and sustained relief compared to cream formulations.

Dosage and Administration

DOSAGE AND ADMINISTRATION For adults 18 years and older:

  • Clean and dry the affected area
  • Locate the tear notch on the edge of the pouch. Tear open at the notch or carefully cut open the pouch with scissors, taking care not to cut the system inside
  • Remove the transparent release liner before applying Salicor™ to the skin
  • Apply one Salicor™ to the affected area of pain and leave it in place for 8 to 12 hours
  • Apply only one Salicor™ at a time
  • If pain persists, the used Salicor™ may be replaced with a new one for up to 8 to 12 more hours
  • Always remove and properly dispose of the used Salicor™ before applying a new one
  • Salicor™ may be cut into smaller sizes with scissors prior to removing the release liner
  • Safely discard the used Salicor™ (whole or cut pieces) where children and pets cannot access it
  • Wash hands with soap and water after applying or removing Salicor™ Visual Guide provided below: These highlights do not include all the information needed to use Salicor™ safely and effectively. See full prescribing information for Salicor™ dosing

    • Drug Interactions

    Drugs That May Cause Methemoglobinemia When Used with Salicor™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class: Nitrates/Nitrites: Local anesthetics: Antineoplastic agents: Antibiotics: Antimalarials: Anticonvulsants: Other drugs: Examples: nitric oxide, nitroglycerin, nitroprusside, nitrous oxide articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides chloroquine, primaquine phenobarbital, phenytoin, sodium valproate acetaminophen, metoclopramide, quinine, sulfasalazine carcinogenesis, mutagenesis

    Pregnancy and Breastfeeding

    Pregnancy Before taking NSAIDs, tell your healthcare provider about all of your medical conditions, including if you are pregnant or plan to become pregnant. Taking NSAIDs at about 20 weeks of pregnancy or later may harm your unborn baby. If you need to take NSAIDs for more than 2 days when you are between 20 and 30 weeks of pregnancy, your healthcare provider may need to monitor the amount of fluid in your womb around your baby. You should not take NSAIDs after about 30 weeks of pregnancy. Pregnancy Category B. Salicor™ has not been studied in pregnancy.

    Overdosage

    OVERDOSAGE Salicor™ is intended for external use only. While systemic toxicity is unlikely with proper use, accidental ingestion or excessive application may lead to salicylate toxicity. Symptoms of overdose may include: nausea and vomiting, tinnitus (ringing in the ears), dizziness and confusion, rapid breathing (hyperventilation), sweating, headache, and fever. In severe cases, overdose may lead to more serious symptoms such as: seizures, hallucinations, respiratory distress, kidney failure, and metabolic acidosis. If overdose is suspected, discontinue use immediately and seek medical attention. Treatment is supportive and symptomatic. Healthcare professionals may need to monitor fluid and electrolyte balance, correct acid-base disturbances, and manage any complications.

    How Supplied

    HOW SUPPLIED Salicor™ is available as the following: 1 carton, 15 systems NDC 83881-501-15

    About This Information

    This drug information is sourced from FDA-approved labeling via the openFDA database. It is intended for educational and reference purposes only. This is not medical advice. Always consult your healthcare provider before making decisions about medication. Drug information may be updated by the FDA; check with your pharmacist for the most current information.

    What are side effects?

    Side effects are unwanted reactions that can occur when taking a medication. They range from mild (headache, nausea) to severe (allergic reactions, organ damage). Not everyone experiences side effects, and severity varies. Report any concerning side effects to your doctor.

    What are drug interactions?

    Drug interactions occur when a medication is affected by another drug, food, or supplement. Interactions can make medications less effective or cause dangerous side effects. Always tell your doctor about all medications and supplements you take.